News-United Well Technologies Limited

Language

EN CN

Home · News & Events

Industry Information

Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy

Novartis scraps mid-stage radiopharma asset as Pluvicto soars

Lutetium-177 PSMA-617 shows promise in earlier-stage prostate cancer

Are Radiopharmaceutical Therapy Trials Designed to Undertreat?

Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer

Tau PET tracer flags early Alzheimer risk in healthy older adults

1 2 3 4 5 6 7 ...